IDEAYA Biosciences, Inc. stock analysis: shares sit near a two-year high while a -36.4% gross margin and 25/100 quality score drive a Sell signal.
Chaudhry Kramat Ali
Chaudhry Kramat Ali
Chaudhry Kramat Ali is the pen name of three doctorate-level friends with expertise spanning finance, economics, and international law. Together, they bring over 30 years of multi-disciplinary experience in value investing — analysing businesses through the lens of fundamentals, institutional ownership data, and long-term capital allocation.
-
-
Insmed Incorporated stock analysis: revenue up 296.1% with a 90/100 growth score, offset by a -76.9% net margin and a Hold signal from our model.
-
IREN Limited stock analysis: a 68.9% gross margin offset by $4.2B of cash burn, revenue down 26.7%, and a Sell signal from our scoring model.
-
Cerebras Systems Inc. stock analysis: CBRS grew revenue 74.3% to $681M, but deep losses and missing valuation data leave the model with no signal.
-
StreetBriefs Weekly
Only 1 Buy Signal Left on the Watchlist as Growth Names Get Priced for Perfection
GitLab, Snowflake and Intel all posted strong weeks – but the model still says Hold on every one.
-
Learn why value investors should track emerging AI startups this fall, focusing on durable moats, cash-flow potential, pricing power, and risks without chasing hype.
-
September Fed signals could reshape value stocks’ inflation defense as investors weigh rates, earnings, credit conditions, and market breadth.